You're sitting in an endocrinologist's office. And there's progesterone showing up where it has no business being. In practice, your testosterone is low — not surprising, maybe — but your estradiol is high. That's why the doctor says "adrenal. The blood work is back. " You say "wait, my adrenals make estrogen?
This changes depending on context. Keep that in mind Most people skip this — try not to..
Yeah. They do. And when they make too much of it — or its cousin, progestin — things get weird fast.
This isn't the usual "low T" story. It's rarer. Day to day, trickier. And honestly? Most guys (and a lot of doctors) miss it entirely And that's really what it comes down to..
What Is Adrenal Estrogen and Progestin Hypersecretion in Males
Let's start with the basics. Even so, your adrenal glands sit on top of your kidneys. They're famous for cortisol and adrenaline. But they also churn out precursor steroids — DHEA, androstenedione, 17-hydroxyprogesterone — that can convert into active sex hormones. Worth adding: estrogen. Progesterone. Even a little testosterone.
In healthy men, this adrenal contribution is background noise. Even so, the rest? Maybe 10–15% of your circulating estrogen comes from adrenal precursors. Testosterone aromatizing in fat, brain, bone, liver No workaround needed..
But sometimes the adrenals go rogue.
The two main drivers
Adrenal tumors — usually adenomas, sometimes carcinomas — can start pumping out estrogen or progestin directly. These are functional tumors. They don't just sit there; they secrete. And because they're not regulated by the usual feedback loops (ACTH, mostly), they don't know when to stop.
Congenital adrenal hyperplasia (CAH) — specifically 21-hydroxylase deficiency or 11β-hydroxylase deficiency — shunts precursor buildup toward sex steroid pathways. In adult males, the non-classic (late-onset) form can fly under the radar for years. You don't get ambiguous genitalia at birth. You get gynecomastia at 34. Or infertility at 29. Or both Practical, not theoretical..
There's also adrenal hyperplasia without a defined enzyme defect — sometimes called "adrenal androgen excess" — where the whole gland is just... But overactive. Now, less common. Harder to pin down Most people skip this — try not to..
What "progestin" even means here
Quick distinction: progesterone is the natural hormone. And it antagonizes androgens. Progestin is the synthetic version in birth control. But in pathology reports, "progestin" often gets used loosely for any progesterone-like activity. In real terms, it binds progesterone receptors. What we're really talking about is excess progesterone or 17-hydroxyprogesterone from the adrenal cortex. It messes with GnRH pulsatility Most people skip this — try not to. Took long enough..
Some disagree here. Fair enough.
Same clinical picture, basically.
Why It Matters / Why People Care
Because the symptoms mimic everything else.
Gynecomastia? Erectile dysfunction? Infertility? Mood swings? And check. Fat redistribution? Low libido? On the flip side, check. Check, check, check, check, check Worth knowing..
A guy walks into his PCP with "man boobs" and soft erections. Then what? Here's the thing — clomid? TRT? Think about it: the doc says "secondary hypogonadism," maybe orders an MRI of the pituitary. In real terms, normal. He gets a testosterone panel. Practically speaking, clean. Free T is low. Total T is low-normal. Maybe slightly suppressed. Practically speaking, lH and FSH are... Neither fixes the root cause.
And here's the kicker: exogenous testosterone makes it worse. Aromatization goes up. Estrogen climbs further. The negative feedback loop tightens. You're pouring gas on a fire you didn't know was burning Small thing, real impact. Which is the point..
The fertility angle
This is where it gets personal for a lot of guys. Excess estrogen suppresses spermatogenesis directly — not just via HPG axis suppression. Estrogen receptors on Sertoli cells, on Leydig cells, on germ cells themselves. High progesterone? Also toxic to sperm maturation. You can have normal-ish testosterone and zero sperm. I've seen it.
And nobody thinks to check adrenal steroids until the third urologist Easy to understand, harder to ignore..
The long-term risks
Chronic unopposed estrogen exposure in males isn't benign. It modulates GABA receptors. There's epidemiological data linking high estradiol in men to cardiovascular events, though causality is debated. Thrombosis risk goes up. In practice, less studied, but it's not inert. Insulin sensitivity tanks. Progesterone excess? Lipid profiles shift — HDL drops, triglycerides rise. It crosses the blood-brain barrier. Anxiety, sleep disruption, weird mood stuff — all documented.
How It Works (Pathophysiology)
The steroidogenic detour
Normal adrenal zona reticularis makes DHEA-S → androstenedione → testosterone/estrone. Worth adding: zona fasciculata makes cortisol. Zona glomerulosa makes aldosterone That's the part that actually makes a difference..
When a tumor or enzyme defect hits, the assembly line breaks.
In 21-hydroxylase deficiency: 17-hydroxyprogesterone piles up. Can't become 11-deoxycortisol. Shunts to androstenedione → estrone/estradiol. Progesterone also accumulates. Both leak into circulation.
In 11β-hydroxylase deficiency: 11-deoxycortisol and deoxycorticosterone (DOC) build up. DOC has mineralocorticoid activity — so you get hypertension alongside the sex steroid excess. That's a clue. Hypokalemia. Alkalosis. The "hypertensive CAH" phenotype.
In estrogen-secreting adrenal adenomas: The tumor cells express aromatase (CYP19A1) — sometimes wildly overexpressed. They take adrenal androgens and convert them in situ to estradiol. Serum estradiol can hit 200, 300, 500 pg/mL. Normal male range? 10–40 And it works..
The feedback chaos
High estrogen → suppresses GnRH → lowers LH/FSH → lowers testicular testosterone. " But the source of suppression is peripheral. So you get low T, high E2, inappropriately normal gonadotropins. Even so, adrenal. But the adrenal keeps pumping. That pattern — low T with non-elevated LH — should scream "central suppression.Not pituitary That's the part that actually makes a difference. That's the whole idea..
Progesterone adds another layer: it competes for 5α-reductase, alters neurosteroid tone, and can directly inhibit LH pulse frequency at the hypothalamus.
Why imaging matters
A 2-cm adrenal mass on CT? Estrogen, progesterone, androgens — sometimes all three. Think about it: adrenal carcinomas are rare (<2 per million) but they love making sex steroids. In practice, they're big (>4 cm), heterogeneous, invasive. But if it's functional — washing out slowly on contrast, Hounsfield units >10 — and your hormones match? So naturally, that's your culprit. Consider this: could be an incidentaloma. You don't want to miss those.
Common Mistakes / What Most People Get Wrong
"Just start TRT and monitor"
I've seen this more times than I can count. Guy has low T, high E2. Doc puts him on 10
mg/week of Testosterone Cypionate. The patient's E2 climbs to 150 pg/mL. The doctor says, "Just add an aromatase inhibitor (AI)." The patient adds Spironolactone. Now he has low T, high E2, and plummeting potassium. On top of that, they are treating the symptom, not the source. And if the source is a steroidogenic enzyme defect or a cortisol-producing adenoma, adding more exogenous testosterone is like throwing gasoline on a grease fire. You are feeding the substrate that the tumor is already converting into estrogen That's the whole idea..
"It's just age-related decline"
The "manopause" myth is a dangerous simplification. While testosterone naturally declines with age, a sudden, precipitous drop accompanied by a spike in estradiol is not "aging"—it is pathology. Clinicians often overlook the adrenal component in men with metabolic syndrome or unexplained hypertension, assuming the endocrine disruption is a result of obesity rather than the driver of it Less friction, more output..
"The lab values are 'normal'"
This is the most insidious error. We must look at the ratio, not just the individual numbers. That's why a male with an estradiol level of 45 pg/mL is technically within the "normal" laboratory range, but for a man with a testosterone level of 250 ng/dL, that ratio is profoundly skewed. "Normal" ranges are derived from population averages, which include people with pathology. A high E2:T ratio is a clinical red flag, regardless of whether the E2 value sits within the upper limit of the reference interval.
Clinical Approach and Management
The management of adrenal-driven steroid excess requires a multi-disciplinary approach involving endocrinology, radiology, and potentially surgical oncology Easy to understand, harder to ignore. No workaround needed..
- Biochemical Confirmation: Do not rely on a single draw. Steroid levels fluctuate. You need a comprehensive panel: Total and Free Testosterone, Estradiol, Progesterone, DHEA-S, 17-OHP, and Cortisol (often via a 1-mg dexamethasone suppression test).
- Imaging Gold Standard: CT or MRI is non-negotiable. You need to characterize the mass (density, margins, enhancement patterns) to differentiate a benign adenoma from a malignant carcinoma.
- Surgical Intervention: If a functional mass is identified, adrenalectomy is typically the definitive treatment. The goal is to remove the source of the enzymatic or aromatase-driven excess.
- Medical Management: In cases where surgery is contraindicated or the mass is non-adenomatous, medications like ketoconazole (which inhibits multiple cytochrome P450 enzymes) may be used to blunt the steroidogenic output, though this is a "band-aid" approach.
Conclusion
Adrenal-driven sex steroid excess is a complex, often overlooked endocrine phenomenon that disrupts the delicate balance of male physiology. Now, whether through enzymatic blocks like 21-hydroxylase deficiency or through the enzymatic overexpression seen in adrenal carcinomas, the result is a profound shift in the androgen-to-estrogen ratio. This shift does more than just lower libido; it alters lipid metabolism, bone density, neurochemistry, and cardiovascular risk.
Clinicians must move beyond the "low T" paradigm and look deeper into the steroidogenic pathway. When a patient presents with the triad of low testosterone, elevated estradiol, and atypical clinical symptoms, the adrenal glands must move to the top of the differential diagnosis. Recognizing the difference between age-related decline and adrenal-driven pathology is the key to preventing long-term metabolic and oncological complications.
